18 – Paediatrician perspectives: a booster shot for the immunisation agenda

in page functions

This session highlighted the unique role of paediatricians in advocating for child health and immunisation

_MG_8685_700F

Copyright GAVI/2011/Saiful Huq Omi

This session highlighted the unique role of paediatricians in advocating for child health and immunisation.

During this session, a breadth of perspectives were shared.

Dr. Sergio Cabral, the moderator and chair of this session, provided an overview of the International Paediatric Association’s advocacy efforts to advance child health and immunisation.

Focusing on the Uganda Paediatric Association, Dr. Sabrina Kitaka followed with a presentation on the importance of evidence in advocacy efforts.

Dr. Naveen Thacker built upon this by examining the approach taken by the Indian Academy of Paediatrics in addressing the concerns of anti-vaccine lobbies in India.

The dual-launch of vaccines for diarrhoea and pneumonia marked a historic event for child health in Tanzania.

Dr. Namala Nkopi provided insight on the Tanzanian Paediatric Society’s engagement in seeing this come to fruition.

On the theme of new vaccines, Dr. Dhana Aryal spoke of the Nepal Paediatrics Society’s advocacy efforts for the introduction of PCV and MR.

Leveraging her experience in the EU, and as a paediatrician herself, Dr. Eleni Theocharous elaborated on her experience in advocating for child health and immunisation.

Dr. Clarrisse Loumou shared the experience of paediatric societies in shaping health policy in francophone Africa. As a Programme and Policy Committee member at GAVI, she also elaborated on how paediatricians can bring the perspectives of communities and countries to shape immunisation and child health policy.

Finally, based on the above case studies, Dr. Adenike Grange of the International Paediatrics Association distilled the specific ways in which paediatricians as a community are well positioned to positively impact child health and advance GAVI’s mission.

168 million

GAVI-supported vaccine campaigns have resulted in 100 million individuals being immunised against meningitis A and 68 million against yellow fever since 2000.

Meningitis A Conjugate Vaccine Immunizaton Campaign. Joint WHO/UNICEF 2011 Progress Report: January to December 2012. March 2013, p.3 | 2011 data. Yellow Fever Initiative. Joint WHO and UNICEF 2011 Progress Report Nov 2012, p.13, 15. 2012 data: Based on data from Epidemiology of Yellow Fever in the African Region: 2012 report. WHO Regional Office for Africa. April 2013, p.6.

More facts...

close icon

modal window here